DE60126495D1 - Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten - Google Patents

Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Info

Publication number
DE60126495D1
DE60126495D1 DE60126495T DE60126495T DE60126495D1 DE 60126495 D1 DE60126495 D1 DE 60126495D1 DE 60126495 T DE60126495 T DE 60126495T DE 60126495 T DE60126495 T DE 60126495T DE 60126495 D1 DE60126495 D1 DE 60126495D1
Authority
DE
Germany
Prior art keywords
cancer
protein
boll
called
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126495T
Other languages
English (en)
Other versions
DE60126495T2 (de
Inventor
Mary Faris
S Hubert
B Raitano
E Afar
Elana Levin
M Challita-Eid
Aya Jakobovits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of DE60126495D1 publication Critical patent/DE60126495D1/de
Application granted granted Critical
Publication of DE60126495T2 publication Critical patent/DE60126495T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60126495T 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten Expired - Lifetime DE60126495T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22709800P 2000-08-22 2000-08-22
US227098P 2000-08-22
US28273901P 2001-04-10 2001-04-10
US282739P 2001-04-10
PCT/US2001/026276 WO2002016593A2 (en) 2000-08-22 2001-08-22 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers

Publications (2)

Publication Number Publication Date
DE60126495D1 true DE60126495D1 (de) 2007-03-22
DE60126495T2 DE60126495T2 (de) 2007-11-29

Family

ID=26921162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126495T Expired - Lifetime DE60126495T2 (de) 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Country Status (11)

Country Link
US (6) US6863892B2 (de)
EP (2) EP1311675B1 (de)
AT (1) ATE353366T1 (de)
AU (2) AU2001285210A1 (de)
CA (1) CA2420543C (de)
DE (1) DE60126495T2 (de)
DK (1) DK1854809T3 (de)
ES (2) ES2281437T3 (de)
HK (1) HK1110876A1 (de)
PT (1) PT1854809E (de)
WO (2) WO2002016593A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
DE60126495T2 (de) * 2000-08-22 2007-11-29 Agensys, Inc., Santa Monica Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
US7223577B2 (en) * 2000-11-17 2007-05-29 Allergan, Inc. Post-translational modifications and Clostridial neurotoxins
WO2004072263A2 (en) * 2003-02-10 2004-08-26 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
CN1846361A (zh) * 2003-08-29 2006-10-11 三星电子株式会社 用于在宽带无线接入通信系统中控制介质接入控制层的操作状态的设备和方法
US7754223B2 (en) * 2003-10-07 2010-07-13 Eurogentec Sa Piscirickettsia salmonis antigens and use thereof
US20110171251A1 (en) * 2004-10-01 2011-07-14 Micael Thiry Piscirickettsia salmonis antigens and use thereof
AU2013200566B2 (en) * 2006-10-17 2014-10-09 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
EP2695895A1 (de) 2006-10-17 2014-02-12 Oncotherapy Science, Inc. Peptidvakzinen für MPHOSPH1- oder DEPDC1-Polypeptide exprimierenden Krebs
US20090090696A1 (en) * 2007-10-08 2009-04-09 Cabot Microelectronics Corporation Slurries for polishing oxide and nitride with high removal rates
WO2009052376A1 (en) * 2007-10-18 2009-04-23 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
EP2231698B9 (de) * 2007-12-19 2014-10-29 Intervet International BV Impfstoffantigene aus piscirickettsia salmonis
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
WO2012169911A1 (en) * 2011-06-10 2012-12-13 Auckland Uniservices Limited Peptides, constructs and uses therefor
GB201115910D0 (en) 2011-09-14 2011-10-26 Univ Manchester Peptides
SG10201701424QA (en) 2012-08-23 2017-04-27 Agensys Inc Antibody drug conjugates (adc) that bind to 158p1d7 proteins
RU2022100330A (ru) 2015-08-12 2022-01-19 Онкотерапи Сайенс, Инк. Пептид, полученный из depdc1, и содержащая его вакцина
CN108489921B (zh) * 2018-05-02 2020-08-11 天津科技大学 一种免双氧水快速检测半胱氨酸的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33504A (en) * 1861-10-15 Improvement in nozzles for hose-pipes
US335074A (en) * 1886-01-26 jewett
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
DE69133528T2 (de) 1990-06-27 2006-09-07 Princeton University Proteinkomplex p53/p90
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
US5783186A (en) * 1995-12-05 1998-07-21 Amgen Inc. Antibody-induced apoptosis
WO1997041255A1 (en) 1996-04-26 1997-11-06 Massachusetts Institute Of Technology Three-hybrid screening assay
US5840501A (en) 1996-10-25 1998-11-24 Bayer Corporation Determination of cPSA
WO2001057188A2 (en) 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
JP2003518920A (ja) 1999-07-02 2003-06-17 カイロン コーポレイション 新規なヒト遺伝子および遺伝子発現産物
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU2001229340A1 (en) 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US7534417B2 (en) * 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
US20060003323A1 (en) * 2000-03-01 2006-01-05 John Alsobrook Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2407449A1 (en) * 2000-04-27 2001-11-01 Smithkline Beecham Corporation Novel compounds
US20040033504A1 (en) * 2001-04-26 2004-02-19 Pankaj Agarwal Novel compounds
JP2004516813A (ja) 2000-06-30 2004-06-10 インサイト・ゲノミックス・インコーポレイテッド 関連腫瘍マーカー
DE60126495T2 (de) 2000-08-22 2007-11-29 Agensys, Inc., Santa Monica Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
CA2419943A1 (en) 2000-09-05 2002-03-14 Incyte Genomics, Inc. Secretory molecules
JP2004509617A (ja) 2000-09-08 2004-04-02 シェーリング　コーポレイション 哺乳動物遺伝子；関連試薬および方法
US6875570B2 (en) * 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
WO2002026826A2 (en) 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
JP2004524819A (ja) * 2000-10-04 2004-08-19 キュラジェン コーポレイション 新規なタンパク質およびこれをコードする核酸ならびにこれらのタンパク質に対する抗体
JP2005503760A (ja) 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US20020192678A1 (en) 2001-02-09 2002-12-19 Huei-Mei Chen Genes expressed in senescence
AU2002322280A1 (en) 2001-06-21 2003-01-21 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20040076955A1 (en) 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
AU2002343417A1 (en) 2001-09-24 2003-04-14 Nuvelo Novel nucleic acids and polypeptides
WO2003035831A2 (en) 2001-10-22 2003-05-01 Exelixis, Inc. Lrrcaps as modifiers of the p53 pathway and methods of use

Also Published As

Publication number Publication date
US20050227253A1 (en) 2005-10-13
US20060018917A1 (en) 2006-01-26
ATE353366T1 (de) 2007-02-15
PT1854809E (pt) 2012-12-26
WO2002016598A2 (en) 2002-02-28
WO2002016593A2 (en) 2002-02-28
ES2281437T3 (es) 2007-10-01
EP1311675A2 (de) 2003-05-21
CA2420543A1 (en) 2002-02-28
WO2002016598A3 (en) 2003-01-23
WO2002016593A3 (en) 2002-12-27
EP1854809A1 (de) 2007-11-14
US20030017466A1 (en) 2003-01-23
US6863892B2 (en) 2005-03-08
AU2001285210A1 (en) 2002-03-04
DK1854809T3 (da) 2013-01-21
HK1110876A1 (en) 2008-07-25
US20030199470A1 (en) 2003-10-23
EP1854809B1 (de) 2012-10-03
ES2395524T3 (es) 2013-02-13
DE60126495T2 (de) 2007-11-29
CA2420543C (en) 2013-04-02
EP1311675B1 (de) 2007-02-07
US20030166526A1 (en) 2003-09-04
AU2001286699A1 (en) 2002-03-04
US20030207835A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
IT8419266A0 (it) Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori.
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
ATE326525T1 (de) Bifidobakterium zur behandlung von entzündungskrankheiten
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
EP0376251A3 (en) An anticoagulant substance obtained from urine
EP1706423B8 (de) Therapeutische und diagnostische anti-hsp 70-antikörper
CY1109029T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου
WO2002014361A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
ATE512216T1 (de) Nukleinsäure und dieser entsprechendes, 184p1e2 genanntes, für die behandlung und den nachweis von krebs geeignetes protein
WO2004072263A3 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
TR199901385T2 (xx) Piperidin t�revleri.
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
WO2002014501A3 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE65543T1 (de) Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
RU99109141A (ru) Способ лечения псориаза
WO2001075022A3 (fr) Nouveau polypeptide, eucaryon acetyl transferase humaine 12, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition